Articles in section Features

<< Editorial

167 articles

General >>

<< Previous

Pages 1 ..10 11 12 13 14 15 .. 17

Next >>

Kos Pharmaceuticals Agrees to Take on Jerini's Icatibant in North America Published: 1 Dec-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 66
Can European VCs and Universities Make Money from New Biotech Spin-Offs? Published: 1 Dec-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 66
Therapy Focus: Neuropathic Pain Published: 1 Dec-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 66
Agensys Fuels Merck & Co.'s Cancer Ambitions Published: 1 Nov-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 65
Galapagos: An Evolving Company Published: 1 Nov-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 65
Trends within the Drug Delivery Sector Published: 1 Nov-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 65
Therapy Focus: Colorectal Cancer Published: 1 Nov-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 65
GSK Keeps an Eye on Vaccines Business with Potential ID Biomedical Acquisition Published: 1 Oct-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 64
EpiCept Merges with Maxim to Go Public Published: 1 Oct-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 64
When and How to Find the Right Partner Published: 1 Oct-2005
By: Business Review Editor
Abstract Fulltext:
Volume: 2005 Issue: 64

Login

Username:

Password:

Keep me logged in